Omar Sued

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

Raphael J. Landovitz, Deborah Donnell, Meredith E. Clement et al. · New England Journal of Medicine · 2021 · 853 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +16

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial

Scott A. Halperin, Lingyun Ye, Donna MacKinnon‐Cameron et al. · The Lancet · 2021 · 237 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

<i>Staphylococcus lugdunensis</i> infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles

Ignasi Anguera, Del Río A, Miró Jm et al. · Heart · 2005 · 200 citations · Full text

Medicine, Cardiology, Infectious Diseases +16

Factors associated with healthcare avoidance among transgender women in Argentina

M. Eugenia Socías, Brandon D. L. Marshall, Inés Arístegui et al. · International Journal for Equity in Health · 2014 · 191 citations · Full text

Social Sciences, Population Health Sciences, Social Determinants Of Health +15

Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial

Pedro Cahn, Jaime Andrade‐Villanueva, José Ramón Arribas et al. · The Lancet Infectious Diseases · 2014 · 156 citations

Pharmacy, Pharmacology, Pharmacotherapy +17